Patients with AD exhibit exaggerated Th2 responses, and initiation of AD lesions is thought to be mediated by means of early skin infiltration of Th2 lymphocytes releasing high levels of IL-4, IL-5, IL-13, and IL-31 [53, 70, 71]. This evidence concerns the gene IL4 and Alzheimer disease.